Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40

Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40

Copyright © 2015 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 162(2016) vom: 01. Jan., Seite 37-44
1. Verfasser: Wang, Junxiang (VerfasserIn)
Weitere Verfasser: Wang, Lu, Xiang, Ying, Ricklin, Daniel, Lambris, John D, Chen, Gang
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Complement inhibitor Cp40 Nonhuman primate SV40-immortalized porcine aortic endothelial cell Complement C3 Peptides mehr... Pyridones 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one 30652-21-2
Online verfügbar Volltext